Larry L. Wood serves as President and Chief Executive Officer of PROCEPT BioRobotics Corporation, a global medical device company pioneering robotic technology for urological surgery. With more than 30 years of leadership experience in the medical technology sector, Mr. Wood has built a distinguished career focused on advancing minimally invasive surgical innovations, commercial scaling, and market expansion. He assumed his role at PROCEPT in 2020, guiding the company through its transformative growth phase. Prior to PROCEPT, Mr. Wood was Executive Vice President and General Manager of Global Business Analytics at Intuitive Surgical, the world leader in robotic-assisted surgery, where he drove data-centric strategies that accelerated international adoption of the da Vinci Surgical System and generated significant revenue growth. Earlier, as President and CEO of Hansen Medical, he orchestrated the company's initial public offering, secured key partnerships, and commercialized the Sensei Robotic Catheter System for cardiac ablation procedures. His tenure at Cardima, Inc., and earlier roles at Baxter Healthcare further honed his expertise in product development, regulatory approvals, and global operations. At PROCEPT BioRobotics, Mr. Wood has spearheaded the successful U.S. IPO in 2021 and the rapid commercialization of the AquaBeam Robotic System, a groundbreaking waterjet-based platform for treating benign prostatic hyperplasia (BPH) with unprecedented precision and safety. Under his stewardship, the company has expanded its clinical footprint, achieved key regulatory milestones, and positioned itself as a frontrunner in urologic robotics, consistently delivering strong procedure growth and advancing patient outcomes worldwide.